tiprankstipranks
XORTX Therapeutics Inc (TSE:XRTX)
:XRTX
Canadian Market
XRTX
XORTX Therapeutics Inc
RESEARCH TOOLSreports
Want to see TSE:XRTX full AI Analyst Report?

XORTX Therapeutics Inc (XRTX) Financial Statements

38 Followers

XORTX Therapeutics Inc Financial Overview

XORTX Therapeutics Inc's market cap is currently C$4.93M. The company's EPS TTM is C$-10.94; its P/E ratio is -6.13; XORTX Therapeutics Inc is scheduled to report earnings on May 16, 2026, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Mar 24Mar 23Mar 22
Income Statement
Total RevenueC$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Gross ProfitC$ -114.08KC$ -160.66K-C$ -75.27KC$ -17.88K
Operating IncomeC$ -3.31MC$ -5.64M-C$ -12.43M-
EBITDAC$ -3.20MC$ -4.38M-C$ -9.41M-
Net IncomeC$ -2.70MC$ -4.54M--C$ -1.65M
Balance Sheet
Cash & Short-Term InvestmentsC$ 862.94KC$ 3.56MC$ 3.45MC$ 10.43MC$ 14.79M
Total AssetsC$ 2.68MC$ 5.89MC$ 5.47MC$ 12.37MC$ 17.38M
Total DebtC$ 37.22KC$ 55.78KC$ 11.51KC$ 77.60KC$ 0.00
Net DebtC$ -825.72KC$ -3.50MC$ -3.44MC$ -10.36MC$ -14.87M
Total LiabilitiesC$ 597.98KC$ 1.09MC$ 825.94KC$ 5.38MC$ 4.18M
Stockholders' EquityC$ 2.08MC$ 4.80MC$ 4.64MC$ 7.00MC$ 13.20M
Cash Flow
Free Cash FlowC$ -2.82MC$ -5.04MC$ -6.63MC$ -9.01MC$ -4.83M
Operating Cash FlowC$ -2.82MC$ -5.04MC$ -6.58MC$ -8.96MC$ -4.80M
Investing Cash FlowC$ -300.12KC$ -53.32KC$ -46.36KC$ -45.70KC$ -31.81K
Financing Cash FlowC$ 1.45MC$ 3.81MC$ -487.30KC$ 4.71MC$ 19.37M
Currency in CAD

XORTX Therapeutics Inc Earnings and Revenue History

Income Statement >

XORTX Therapeutics Inc Debt to Assets

Balance Sheet >

XORTX Therapeutics Inc Cash Flow

Cash Flow >

XORTX Therapeutics Inc Forecast EPS vs Actual EPS

Earnings >